SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-16-105668
Filing Date
2016-05-31
Accepted
2016-05-31 06:25:22
Documents
5
Period of Report
2016-05-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v441287_8k.htm 8-K 36820
2 EXHIBIT 2.1 v441287_ex2-1.htm EX-2.1 459759
3 EXHIBIT 3.1 v441287_ex3-1.htm EX-3.1 87971
4 EXHIBIT 99.1 v441287_ex99-1.htm EX-99.1 30820
5 GRAPHIC tex99-1logo.jpg GRAPHIC 14461
  Complete submission text file 0001144204-16-105668.txt   636637
Mailing Address 303B COLLEGE ROAD EAST PRINCETON NJ 08540
Business Address 303B COLLEGE ROAD EAST PRINCETON NJ 08540 (609) 243-0123
Celator Pharmaceuticals Inc (Filer) CIK: 0001327467 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36179 | Film No.: 161683855
SIC: 2834 Pharmaceutical Preparations